Screener
Sana Biotechnology SANA Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Sana Biotechnology’s reported figures.
Based on the most recent quarter.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
FAQ
- What is Sana Biotechnology's debt-to-equity?
- Sana Biotechnology (SANA) reported debt-to-equity of 0.6× in Q1 2026.
- How has Sana Biotechnology's debt-to-equity changed year-over-year?
- Sana Biotechnology's debt-to-equity increased by 44.7% year-over-year, from 0.4× to 0.6×.
- What is the long-term trend for Sana Biotechnology's debt-to-equity?
- Over 4 years (2021 to 2025), Sana Biotechnology's debt-to-equity has grown at a 33.9% compound annual growth rate (CAGR), from 0.2× to 0.5×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Sana Biotechnology's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude